TOP STORIES

• BUSINESS Decision on Pfizer Vaccine Unlikely to Come before Japan Data Submission Slated by February
  December 21, 2020

• BUSINESS Pfizer/BioNTech’s COVID-19 Vaccine Filed in Japan, Exceptional OK Eyed
  December 18, 2020

• BUSINESS 5%-Plus Discrepancy Threshold for Off-Year Re-Pricing Draws Fire from Pharma, Wholesalers
  December 18, 2020

• REGULATORY Ministers Agree on 5%-Plus Price Discrepancy Line for Off-Year Re-Pricing; 59% Coverage for Innovative Meds, 88% for LLPs, 83% for Gx
  December 18, 2020

• REGULATORY Govt Settles on Discrepancy Rate Threshold of “Above 5%” for Off-Year Drug Re-Pricing, 430 Billion Yen Reduction, 60% Coverage for Innovative Meds
  December 17, 2020

• REGULATORY Japan Govt Eyes 4-6% Price Discrepancy Threshold for Off-Year Drug Re-Pricing
  December 16, 2020

• BUSINESS UCB Japan to Independently Market New Products; Stand-Alone E Keppra Sales “Going Smoothly”: President
  December 16, 2020

• REGULATORY Japan Weighs Drug Cost Cut of around 400 Billion Yen in Off-Year Re-Pricing, Expanded Coverage Including Products with Smaller-than-Average Price Gap Too
  December 15, 2020

• BUSINESS Forxiga Filed for Chronic Kidney Disease in Japan: AZ
  December 15, 2020

• BUSINESS 1st Death Reported for Kobayashi Kako’s Tainted Itraconazole Product
  December 14, 2020

• REGULATORY MHLW Unveils Overview of COVID-19 Vaccine Distribution Scheme in Japan
  December 11, 2020

• BUSINESS Boehringer Speeding Up Growth of Jardiance on Organization, Alliance Rejig; 40 Billion Yen Japan Sales Likely in 2020
  December 11, 2020

• BUSINESS Aducanumab Submitted in Japan, but Decision Unlikely to Come Until Next Autumn
  December 11, 2020

• BUSINESS Biogen Files Japan NDA for Aducanumab
  December 10, 2020

• REGULATORY Chuikyo Healthcare Reps Urge Minimal Scope for Off-Year Re-Pricing, Payers Grumble over Generic-Heavy Coverage
  December 10, 2020

• BUSINESS Takeda Aiming for Sales of 5 Trillion Yen by FY2030, Sees It Realistic Target with Strong Pipeline
  December 10, 2020

• REGULATORY MHLW Estimates: Off-Year Re-Pricing with Average Price Gap Threshold Likely to Hit 8,700 Products, Save 360 Billion Yen
  December 9, 2020

• BUSINESS Kyle Tattle to Take Reins of MSD Japan from January
  December 8, 2020

• REGULATORY MHLW Panel OKs Takeda’s ALK Drug, Lynparza’s Pancreatic Cancer Use; Seikagaku’s Osteoarthritis Med Put under Continued Review
  December 7, 2020

• REGULATORY Gardasil’s Male Indication in Line for OK as Early as This Month
  December 7, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 98
• 99
• 100
• 101
• 102
• 103
• 104
• 105
• 106
• …
• Next ›
• 最終 »